Kerecis Real-World Fish Skin Graft Registry

NCT06384183 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-12-30

No results posted yet for this study

Summary

Multi-center, observational (i.e., non-interventional), open-label, real-world Registry on the Use of Kerecis Devices

Conditions

  • Wounds
  • Pressure Ulcer
  • Diabetic Foot Ulcer
  • Venous Leg Ulcer
  • Surgical Wound
  • Soft Tissue Reinforcement

Interventions

DEVICE

Kerecis Fish Skin Graft

Patients already treated with a Kerecis device

Sponsors & Collaborators

  • Kerecis Ltd.

    lead INDUSTRY

Principal Investigators

  • Anne Swearingen · Kerecis Ltd.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-07
Primary Completion
2026-06-30
Completion
2027-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06384183 on ClinicalTrials.gov